Anticoagulants Flashcards

0
Q

Vascular injury

A

Platelets adhere

Tissue factor is released

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Anticoagulant

A

Targets clotting factors/cascade

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Virchows triad for thrombus formation

A

1) Damaged endothelium
2) Hypercoagulability: smoking, estrogen
3) slow blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Arterial thrombi

A

Prevent/TX: antiplatelet, anticoagulant agents

Due to high blood flow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Venous thrombi

A

Static blood flow
High clotting factors

Prevention/tx: anticoagulants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Vitamin K factors

A

2, 7, 9, 10

Target major sites 2,10 are most important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

UFH

A

Inhibit II, X equally, binds ATIII

Nonlinear dose response

Interpatient clearance variability based on weight

Easily reversible with protamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

LMWH

A

Inhibit II and X (more X)

Linear Dose response

Lovenox SC

Dose adjustment in renal impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Fondaparinux

A

X inhibitor

Linear dose adjustment

Once daily dosing

Contraindicated in CrCl <30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Heparin

A

Accelerates ATIII activity to neutralize clotting factors (Xa IIa)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Warfarin pharmacometrics

A

Blood levels
Inhibit vit K reductase
Synthesis rate and half-life
INR prothrombin time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Warfarin pharmacokinetics

A

S isomer more active than R

Highly protein bound

S-2C9 metabolism R-3A4

Inhibits vitamin K VKOR (coagulation protein production)

Vitamin K antidote if INR>10

Smoking increases clearance
Chronic alcohol increases metabolism

Overall elimination not a factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Warfarin onset

A

Based on clotting factor degradation

Protein C, S limit thrombosis but degrade first place causing increased prothrombin time

1-3 weeks to reach stable INR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Warfarin inhibition

A

S:Fluconazole, Amiodarone
R: quinolones (levofloxacin)

Variance explained by VKOR and 2C9 differences

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Warfarin INR goals

A

2-3 in normal patient

2.5-3.5 if prosthetic heart valve

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Acetaminophen

A

Analgesic of choice for those on warfarin

16
Q

Dabigatran

A

IIa inhibitor

Affected by Pgp and 3A4

Requires renal function

BID dosing

17
Q

New oral anticoagulants appropriate

A

CrCl>30
Difficulty with INR a monitoring
Concern with food interactions

NOT for prosthetic valve, renal impairment, GI bleed, noncompliance, cost